Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification.
PUBG's very own Brenden Green - better known as PlayerUnknown - wants his new simulation game, made at his new studio, to ...
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its ...
21h
Cognitively, some people also have a reasoning style that more quickly jumps to conclusions, Halassa said. People who are ...
Interview | "There's a lot of preconceived notions when you say 'survival game'", and Prologue: Go Wayback isn't particularly ...
For patients with previously untreated chronic lymphocytic leukemia (CLL), fixed-duration acalabrutinib-venetoclax wit ...
Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.
Panelists discuss how CARTITUDE-4 demonstrated superior progression-free survival and overall response rates with ...
We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...
Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...
No improvement in overall survival (OS) was observed with palbociclib (Verzenio) plus endocrine therapy versus capecitabine ...
Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback